Abstract
It is still controversial whether pre-existing cerebral microbleeds (CMBs) increase the risks of intracranial hemorrhage (ICH) and poor functional outcome (PFO) in acute ischemic stroke (AIS) patients treated with intravenous thrombolysis (IVT). Therefore, we performed a systematic review and meta-analysis to determine the impact of CMBs on ICH and PFO of AIS patients with IVT. We searched PubMed, EMBASE and Web of Science from inception to August 3, 2016, with language restriction in English. We included studies that reported the relationship between CMBs and ICH or PFO after thrombolysis. Two retrospective and nine prospective studies met inclusion criteria (total 2702 patients). The overall prevalence of CMBs on pre-IVT MRI scans was 24.0%. Pre-existing CMBs on MRI scans were not significantly associated with a higher risk of early sICH (OR 1.74; 95% CI 0.91–3.33; I 2 = 44.5%). Subgroup analyses did not substantially influence these associations. The presence of CMBs was associated with the increased risk of 3-month PFO (OR 1.58; 95% CI 1.08–2.31; I 2 = 54.2%), PH (OR 2.14; 95% CI 1.34–3.42; I 2 = 11.0%) and any ICH (OR 1.42; 95% CI 1.04–1.95; I 2 = 0.0%), respectively. This meta-analysis showed that CMBs presence was not significantly associated with the increased risk of early sICH after IVT. However, the results also demonstrated that CMBs presence increased the risks of 3-month PFO, PH and any ICH after IVT. Due to a small number of included studies and methodological limitations, the results of this meta-analysis should be interpreted cautiously. CMBs presence should not be a contraindication to IVT for AIS patients based on the existing evidence.
Similar content being viewed by others
References
Endres M, Heuschmann PU, Laufs U, Hakim AM (2011) Primary prevention of stroke: blood pressure, lipids, and heart failure. Eur Heart J 32(5):545–552
Emberson J, Lees K, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Stroke Thrombolysis Trialists’ Collaborative Group (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384(9958):1929–1935
Atlantis T (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363(9411):768–774
Yaghi S, Boehme AK, Dibu J, Guerrero CRL, Ali S, Martin-Schild S, Sands KA, Noorian AR, Blum CA, Chaudhary S (2015) Treatment and outcome of thrombolysis-related hemorrhage: a multicenter retrospective study. JAMA Neurol 72(12):1451–1457
Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman RA-S, Warach S, Launer LJ, Van Buchem MA, Breteler MM, Group MS (2009) Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 8(2):165–174
Cordonnier C, Salman RA-S, Wardlaw J (2007) Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130(8):1988–2003
Poels MMF, Vernooij MW, Ikram MA, Hofman A, Krestin GP, Der Lugt AV, Breteler MMB (2010) Prevalence and risk factors of cerebral microbleeds an update of the Rotterdam scan study. Stroke:41
Gregoire SM, Brown MM, Kallis C, Jager R, Yousry TA, Werring DJ (2010) MRI detection of new microbleeds in patients with ischemic stroke. Five-year cohort follow-up study. Stroke 41(1):184–186
Orken DN, Uysal E, Timer E, Kuloglu-Pazarcı N, Mumcu S, Forta H (2013) New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up. Clin Neurol Neurosurg 115(9):1682–1685
Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W, Ding M, Gao X (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 7(6):494–499
Yan S, Jin X, Zhang X, Zhang S, Liebeskind DS, Lou M (2015) Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis. J Neurol Neurosurg Psychiatry 86(11):1267–1272. doi:10.1136/jnnp-2014-309857
Turc G, Sallem A, Moulin S, Tisserand M, Machet A, Edjlali M, Baron JC, Leclerc X, Leys D, Mas JL, Cordonnier C, Oppenheim C (2015) Microbleed status and 3-month outcome after intravenous thrombolysis in 717 patients with acute ischemic stroke. Stroke 46(9):2458–2463. doi:10.1161/strokeaha.115.009290
Dannenberg S, Scheitz JF, Rozanski M, Erdur H, Brunecker P, Werring DJ, Fiebach JB, Nolte CH (2014) Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke 45(10):2900–2905. doi:10.1161/strokeaha.114.006448
Cai J, Fu J, Yan S, Hu H, Lin C (2015) Clinical outcome in acute ischemic stroke patients with microbleeds after thrombolytic therapy: a meta-Analysis. Medicine 94(52):e2379. doi:10.1097/md.0000000000002379
Charidimou A, Shoamanesh A, Wilson D, Gang Q, Fox Z, Jager HR, Benavente OR, Werring DJ (2015) Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk updated meta-analysis. Neurology 85(11):927–934. doi:10.1212/wnl.0000000000001923
Tsivgoulis G, Zand R, Katsanos AH, Turc G, Nolte CH, Jung S, Cordonnier C, Fiebach JB, Scheitz JF, Klinger-Gratz PP, Oppenheim C, Goyal N, Safouris A, Mattle HP, Alexandrov AW, Schellinger PD, Alexandrov AV (2016) Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis. JAMA Neurol 73(6):675–683. doi:10.1001/jamaneurol.2016.0292
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269. doi:10.7326/0003-4819-151-4-200908180-00135
Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses
Higgins JPT, Thompson S, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Egger M, Smith GD, Schneider M, Minder CE (1997) Bias in meta›analysis detected by a simple, graphical test. BMJ 315(7109):629
Annan M, Cottier JP, Gaudron M, Dejobert M, De Toffol B, Debiais S (2015) Microbleeds: not more hemorrhagic transformation after thrombolysis. Eur J Neurol 22:126
Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J, Yilmaz H, Dardel P, Froment JC, Trouillas P (2004) Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis (Basel, Switzerland) 17(2–3):238–241. doi:10.1159/000076123
Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, Kim JS, Liebeskind DS, Neumann-Haefelin T, Pedraza S, Rother J, Rothwell P, Rovira A, Schellinger PD, Trenkler J, Grp MS (2007) Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL)—pooled analysis of t2*-weighted magnetic resonance imaging data from 570 patients. Stroke 38(10):2738–2744. doi:10.1161/strokeaha.106.480848
Gratz PP, El-Koussy M, Hsieh K, von Arx S, Mono ML, Heldner MR, Fischer U, Mattle HP, Zubler C, Schroth G, Gralla J, Arnold M, Jung S (2014) Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke 45(6):1684–1688. doi:10.1161/strokeaha.114.004796
Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S, Moseley ME, Marks MP, Albers GW, Investigators D (2005) Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 65(8):1175–1178. doi:10.1212/01.wnl.0000180519.27680.0f
Kimura K, Aoki J, Shibazaki K, Saji N, Uemura J, Sakamoto Y (2013) New appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration. Stroke 44(10):2776–2781. doi:10.1161/strokeaha.113.001778
Moriya Y, Takahashi W, Kijima C, Yutani S, Iijima E, Mizuma A, Honma K, Uesugi T, Ohnuki Y, Nagata E, Yanagimachi N, Takizawa S (2013) Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke. Tokai J Exp Clin Med 38(1):24–27
Takahashi Y, Morihara R, Narai H, Omori N, Manabe Y (2014) Acute neuroimaging analysis of the risk of hemorrhagic complications in acute ischemic stroke patients with microbleeds after intravenous recombinant tissue plasminogen activator therapy. Int J Stroke 9:57–58
Shoamanesh A, Kwok CS, Lim PA, Benavente OR (2013) Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke 8(5):348–356. doi:10.1111/j.1747-4949.2012.00869.x
Wu Y, Chen T (2016) An Up-To-Date Review On Cerebral Microbleeds. J Stroke Cerebrovasc Dis 25(6):1301–1306. doi:10.1016/j.jstrokecerebrovasdis.2016.03.005
Smith EE, Greenberg SM (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56(4):537–539
Yakushiji Y (2015) Cerebral microbleeds: detection, associations and clinical implications. Front Neurol Neurosci 37:78–92. doi:10.1159/000437115
Viswanathan M, Salman RA-S, Steven Warach M, Lenore J (2009) Cerebral microbleeds: a field guide to their detection and interpretation. Lancet Neurol 8(2):165–174
Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am J Neuroradiol 20(4):637–642
Dzialowski I, Pexman JW, Barber PA, Demchuk AM, Buchan AM, Hill MD, Investigators C (2007) Asymptomatic hemorrhage after thrombolysis may not be benign prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study Registry. Stroke 38(1):75–79
Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, Guyatt G, Devereaux PJ, Thabane L (2011) The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis—a simulation study. PLoS One 6(10):e25491
Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W (2008) Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST). Stroke 39(12):3316–3322
Arsava E, Rahman R, Rosand J, Lu J, Smith E, Rost N, Singhal A, Lev M, Furie K, Koroshetz W (2009) Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 72(16):1403–1410
Cheng A-L, Batool S, McCreary CR, Lauzon M, Frayne R, Goyal M, Smith EE (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 44(10):2782–2786
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The manuscript does not contain clinical studies or patient data.
Funding
No sources of funding were used to assist the preparation of this study.
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
S. Wang and Y. Lv equally contributed to this article.
Rights and permissions
About this article
Cite this article
Wang, S., Lv, Y., Zheng, X. et al. The impact of cerebral microbleeds on intracerebral hemorrhage and poor functional outcome of acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis. J Neurol 264, 1309–1319 (2017). https://doi.org/10.1007/s00415-016-8339-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-016-8339-1